Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<IPO>Legend Biotech Plans to List in HK as Early as This Yr, Raising at Least US$300M: Wire
Recommend 0 Positive 4 Negative 0 |
||||
|
||||
|
Legend Biotech (LEGN.US), a joint venture of GENSCRIPT BIO (01548.HK), planned to list in Hong Kong as early as this year, aiming to raise US$300-400 million, according to IFR. Legend Biotech was founded in 2014 and is the world's largest standalone cell therapy company, according to the Company's website. AASTOCKS Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
